GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Price-to-Funds-From-Operations

Legend Biotech (Legend Biotech) Price-to-Funds-From-Operations : (As of Jun. 10, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Legend Biotech (Legend Biotech) Business Description

Industry
Traded in Other Exchanges
Address
2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.